Palvella Therapeutics, Inc (PVLA) valuation · rev $42.8M
Palvella Therapeutics, Inc (PVLA) rev $42.8M.
| Metric | Value |
|---|---|
| Market cap | $1.64B |
| Revenue | $42.8M |
| P/S | 38.3 |
| P/B | 7.0 |
PVLA valuation FAQ
What is PVLA's market cap?
Palvella Therapeutics, Inc (PVLA) market cap is $1.64B on the latest cached fundamentals snapshot.
What is PVLA's latest revenue?
Latest cached Palvella Therapeutics, Inc (PVLA) revenue was $42.8M. Statements: https://lician.com/financials/pvla
What is PVLA's price-to-sales ratio?
Palvella Therapeutics, Inc (PVLA) price-to-sales (P/S) is 38.3, cached market cap $1.64B divided by revenue $42.8M.
What is PVLA's price-to-book ratio?
Palvella Therapeutics, Inc (PVLA) price-to-book (P/B) is 7.0 on the latest cached fundamentals snapshot.
How many PVLA valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Palvella Therapeutics, Inc (PVLA): Market cap, Revenue, P/S, and P/B.
Where is PVLA valuation listed?
Cached valuation multiples for Palvella Therapeutics, Inc (PVLA) are listed at https://lician.com/valuation/pvla.
Not investment advice. Cached rows, not a live tape.